{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:34:26Z","timestamp":1777581266523,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]},{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]},{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]},{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]},{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]},{"name":"Natural Science Foundation Joint Project of Ningde, China","award":["Grant\/Award Number: 2022J54"],"award-info":[{"award-number":["Grant\/Award Number: 2022J54"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to assess and compare procalcitonin (PCT) and C-reactive protein (CRP) levels between COVID-19 and non-COVID-19 sepsis patients. Additionally, we evaluated the diagnostic efficiency of PCT and CRP in distinguishing between Gram-positive (GP) and Gram-negative (GN) bacterial infections. Moreover, we explored the associations of PCT with specific pathogens in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 121 consecutive sepsis patients who underwent blood culture testing during the COVID-19 epidemic. PCT and CRP were measured, and reverse transcriptase-polymerase chain reaction (RT-PCR) was employed for the detection of COVID-19 nucleic acid. The Mann-Whitney U-test was used to compare PCT and CRP between the COVID-19 and non-COVID-19 groups. Receiver operating characteristic (ROC) curves were generated to compare PCT and CRP levels in the GN group versus the GP group for assessing the diagnostic efficiency. The kruskal-Wallis H test was applied to assess the impact of specific pathogen groups on PCT concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 121 sepsis patients were categorized into a COVID-19 group (n\u2009=\u200925) and a non-COVID-19 group (n\u2009=\u200996). No significant differences in age and gender were observed between the COVID-19 and non-COVID-19 groups. The comparison of biomarkers between these groups showed no statistically significant differences. The optimal cut-off values for PCT and CRP in differentiating between GP and GN infections were 1.03 ng\/mL and 34.02\u00a0mg\/L, respectively. The area under the ROC curve was 0.689 (95% confidence interval (CI) 0.591\u20130.786) for PCT and 0.611 (95% CI 0.505\u20130.717) for CRP. The diagnostic accuracy was 69.42% for PCT and 58.69% for CRP. The study found a significant difference in PCT levels among specific groups of pathogens (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), with the highest levels observed in\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      infections. The frequency of\n                      <jats:italic>Staphylococcus spp.<\/jats:italic>\n                      positive results was significantly higher (36.0%) in COVID-19 compared to non-COVID-19 sepsis patients (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Sepsis patients with COVID-19 revealed a significantly higher culture positivity for\n                      <jats:italic>staphylococcus spp.<\/jats:italic>\n                      than the non-COVID-19 group. Both PCT and CRP showed moderate diagnostic efficiency in differentiating between GP and GN bacterial infections. PCT showed potential utility in identifying\n                      <jats:italic>E. coli<\/jats:italic>\n                      infections compared to other pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08962-x","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:01:59Z","timestamp":1704319319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Procalcitonin and C-reactive protein as diagnostic biomarkers in COVID-19 and Non-COVID-19 sepsis patients: a comparative study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-E","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Hui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"issue":"4","key":"8962_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","volume":"104","author":"MD FONT","year":"2020","unstructured":"Font MD, Khanna Thyagarajanb. Sepsis and septic shock - basics of diagnosis, pathophysiology and clinical decision making [J]. Med Clin North Am. 2020;104(4):573\u201385.","journal-title":"Med Clin North Am"},{"issue":"2","key":"8962_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14787210.2019.1562335","volume":"17","author":"M BASSETTI","year":"2019","unstructured":"Bassetti M, Russo A, Righi E, et al. Role of procalcitonin in bacteremic patients and its potential use in predicting Infection etiology [J]. Expert Rev Anti Infect Ther. 2019;17(2):99\u2013105.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"8962_CR3","doi-asserted-by":"publisher","first-page":"607647","DOI":"10.3389\/fped.2020.607647","volume":"8","author":"M SAMPRATHI","year":"2020","unstructured":"Samprathi M. Biomarkers in COVID-19: an Up-To-Date review [J]. Front Pediatr. 2020;8:607647.","journal-title":"Front Pediatr"},{"issue":"3","key":"8962_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4997\/jrcpe.2019.308","volume":"49","author":"A RAVEENDRAN A V, KUMAR","year":"2019","unstructured":"Raveendran A V, Kumar A. Biomarkers and newer laboratory investigations in the diagnosis of sepsis [J]. J R Coll Physicians Edinb. 2019;49(3):207\u201316.","journal-title":"J R Coll Physicians Edinb"},{"issue":"1","key":"8962_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12879-022-07125-8","volume":"22","author":"Y LI","year":"2022","unstructured":"Li Y, Wu Y, Gao Y, et al. Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis Infection and bacterial bloodstream infection: a singled centered retrospective study [J]. BMC Infect Dis. 2022;22(1):150.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8962_CR6","doi-asserted-by":"publisher","first-page":"15466","DOI":"10.1038\/s41598-022-19643-1","volume":"12","author":"DAMBROSO-ALTAFINI D","year":"2022","unstructured":"Dambroso-Altafini D, Menegucci TC, Costa BB, et al. Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections [J]. Sci Rep. 2022;12(1):15466.","journal-title":"Sci Rep"},{"issue":"1","key":"8962_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12879-021-06064-0","volume":"21","author":"S CONG","year":"2021","unstructured":"Cong S, Ma T, Di X, et al. Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis [J]. BMC Infect Dis. 2021;21(1):384.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"8962_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C WACKER","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst F M, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis [J]. Lancet Infect Dis. 2013;13(5):426\u201335.","journal-title":"Lancet Infect Dis"},{"key":"8962_CR9","doi-asserted-by":"crossref","unstructured":"Hung SK, Lan HM, Han ST et al. Current evidence and limitation of biomarkers for detecting Sepsis and Systemic Infection [J]. Biomedicines, 2020, 8(11).","DOI":"10.3390\/biomedicines8110494"},{"key":"8962_CR10","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.2147\/IJGM.S327958","volume":"14","author":"S ZHU","year":"2021","unstructured":"Zhu S, Zeng C, Zou Y, et al. The clinical diagnostic values of SAA, PCT, CRP, and IL-6 in children with bacterial, viral, or co-infections [J]. Int J Gen Med. 2021;14:7107\u201313.","journal-title":"Int J Gen Med"},{"key":"8962_CR11","doi-asserted-by":"crossref","unstructured":"Escand\u00f3n K, Rasmussen AL, Bogoch, II, et al. COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection [J]. BMC Infect Dis. 2021;21(1):710.","DOI":"10.1186\/s12879-021-06357-4"},{"issue":"8","key":"8962_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M SINGER","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"8962_CR13","unstructured":"National Health Commission & State Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial 9th version). [M]. 2022."},{"issue":"11","key":"8962_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"GLAS A S","year":"2003","unstructured":"Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance [J]. J Clin Epidemiol. 2003;56(11):1129\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"8962_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","volume":"22","author":"DO THOMAS-R\u00fcDDEL","year":"2018","unstructured":"Thomas-R\u00fcddel DO, Poidinger B. Influence of pathogen and focus of Infection on procalcitonin values in sepsis patients with bacteremia or candidemia [J]. Crit Care. 2018;22(1):128.","journal-title":"Crit Care"},{"issue":"1","key":"8962_CR16","doi-asserted-by":"publisher","first-page":"e0262342","DOI":"10.1371\/journal.pone.0262342","volume":"17","author":"ATALLAH N J","year":"2022","unstructured":"Atallah NJ, Warren HM, Roberts MB, et al. Baseline procalcitonin as a predictor of bacterial Infection and clinical outcomes in COVID-19: a case-control study [J]. PLoS ONE. 2022;17(1):e0262342.","journal-title":"PLoS ONE"},{"issue":"1","key":"8962_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-023-00450-3","volume":"11","author":"A OUSSALAH","year":"2023","unstructured":"Oussalah A, Callet J, Manteaux AE, et al. Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream Infection: an observational cohort study [J]. Biomark Res. 2023;11(1):4.","journal-title":"Biomark Res"},{"issue":"5","key":"8962_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00011-012-0439-5","volume":"61","author":"MATWIYOFF G N","year":"2012","unstructured":"Matwiyoff GN, Prahl JD, Miller RJ, et al. Immune regulation of procalcitonin: a biomarker and mediator of Infection [J]. Inflamm Res. 2012;61(5):401\u20139.","journal-title":"Inflamm Res"},{"issue":"3","key":"8962_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/cc6862","volume":"12","author":"H GAO","year":"2008","unstructured":"Gao H, Evans T W, Finney SJ. Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? [J]. Crit Care. 2008;12(3):213.","journal-title":"Crit Care"},{"issue":"2","key":"8962_CR20","first-page":"1097","volume":"25","author":"ZHOU Y Z","year":"2021","unstructured":"Zhou YZ, Teng XB, Han MF, et al. The value of PCT, IL-6, and CRP in the early diagnosis and evaluation of COVID-19 [J]. Eur Rev Med Pharmacol Sci. 2021;25(2):1097\u2013100.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08962-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08962-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08962-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T10:07:52Z","timestamp":1704362872000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08962-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8962"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08962-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3336975\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from Medical Ethics Committee of Fuding Hospital, Fujian University of Traditional Chinese Medicine (ethnical approval number: Fuding 2023001). All methods were conducted according to relevant guidelines and regulations. Informed consent from participants were waived by Medical Ethics Committee of Fuding Hospital, Fujian University of Traditional Chinese Medicine due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}